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oestrogen receptor (ESR) gene are infertile with cystic
Especially PvuII and BstUI polymorphisms have been associated ovaries and follicular arrest. In humans, several polywith breast cancer and spontaneous abortions (Lehrer et al. , morphisms and mutations in the ESR gene have been 1993; Andersen et al., 1994) .
identified. In this study we have analysed a common PvuII
The recently applied new technology in assisted reproducand a rare BstUI polymorphism in the ESR gene. Analysis tion, including ovarian stimulation regimes, has shown variawas carried out on DNA samples from women undergoing bility in ovarian response to treatment. Whether variability in ovarian stimulation for in-vitro fertilization (IVF) and the ESR gene is partly related to ovarian response has not embryo transfer and controls having at least one pregnancy.
been investigated, and no studies have been published on this Comparisons were done between the three PvuII genotypes, relationship yet.
concerning the mean numbers of follicles and oocytes and
We have analysed the two polymorphisms of the ESR the mean ratios of follicles to oocytes harvested in two gene in patients undergoing ovarian stimulation for in-vitro consecutive cycles. Significantly lower ratios were identified fertilization (IVF) and embryo transfer in order to assess the in the group lacking the PvuII polymorphism, compared numbers of follicles and oocytes produced by individuals with the groups with heterozygous or homozygous PvuII having different ESR genotypes. In particular two questions polymorphisms (P > 0.05 and P > 0.01 respectively). The were addressed: (i) do polymorphisms affect response, and (ii) rare haplotype having both PvuII and BstUI restriction is the incidence of particular polymorphisms different in sites on one chromosome was present only in the IVF women undergoing IVF than in controls? group. Pregnancies from IVF were significantly rarer in patients who were homozygous for the PvuII polymorphism (P > 0.05). Our results suggest that genetic variability in Materials and methods the ESR has a role in the quality of the ovarian follicles as
The study included 100 normally ovulating infertile women, [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] judged by the ovarian response to stimulation and may years of age, undergoing IVF and embryo transfer treatment in our also affect implantation.
infertility unit, and a control group of 100 randomly selected normally Introduction cases with Ͼ50% variation in the numbers of follicles and oocytes
The oestrogen receptor (ESR) is a potent mediator of oestrobetween successive cycles, poor response, hyperstimulation and single ovaries were excluded. In general, to minimize the degree of variation genic action in target tissues (Yamamoto, 1985) . It is believed to in ovarian response, only normally cycling women with tubal or mediate autocrine oestrogen action in granulosa cells (Richards, unexplained infertility were included, while cases with conditions 1975). Oestrogen and follicle stimulating hormone (FSH) act potentially affecting ovarian response, such as endometriosis and in synergism in the ovary to increase the number of FSH polycystic ovary syndrome, were excluded from the study.
receptors in the granulosa cells, resulting in follicular growth Follicular growth was stimulated by the long protocol using a and maturation (Goldenberg et al., 1972; Richards et al., daily dose of 0.2 ml leuprolide (Daronda, 2.8 ml; Abott, Chicago, 1976; Ireland and Richards, 1978) . FSH-stimulated aromatase IL, USA) given s.c. for 14 days, in combination with a fixed regimen activity, progestin and cAMP biosynthesis in cultured granulosa of three ampoules (225 IU) of human menopausal gonadotrophin cells are enhanced by oestrogens (Adashi and Hsueh, 1982;  (HMG) given i.m. daily, and luteal support by the administration of progesterone (Utrogestan; B.I., Paris, France) at the dose of 600 mg ultrasonography and oestradiol-17β measurements.
Oocyte no. 7.8 Ϯ 3.2 6.6 Ϯ 3.6 6.7 Ϯ 3.9
The same clinical and laboratory staff was involved in follicular person responsible for DNA analysis blind to the oocyte retrieval.
Values are means Ϯ SD with ranges in parentheses.
Peripheral blood samples were obtained the day of oocyte collection a,b Significantly different from pp group: P Ͻ 0.05 and P Ͻ 0.01 from all patients, the controls and their parents, for DNA isolation respectively.
by the salt extraction method. Paternal DNA was used for the construction of the haplotypes. PCR amplification was carried out according to Yaich et al. (1992) The patients were assigned to groups according to their ESR polyTotal 37 100 morphisms and haplotypes. In each group the numbers of follicles, oocytes and ratios of follicles to oocytes from both treatment cycles of every patient were recorded immediately after aspiration. The in both groups with the exception of haplotype P-B which was range of 10-26 mm-sized follicles was selected to include the majority found only in the IVF group (Table II) .
of oocytes with normal morphology which were fertilizable. The Table III summarizes the mean numbers, SD and range for mean numbers of follicles, oocytes and ratios were used for the follicle number, oocyte number and ratio of follicle to oocyte statistical analysis. In addition, the number of HMG ampoules, the duration of HMG administration and the causes of infertility (tubal numbers in each PvuII genotype group.
or unexplained) were also recorded. Clinical pregnancies were evalu-A statistically significant difference was found only between ated by human chorionic gonadotrophin (HCG) measurements and the ratio of follicle to oocyte numbers in the three groups of ultrasonography.
PvuII genotypes, but not between follicles and oocytes when pp (46%) and the Pp (46%) genotypes and only three in a total of 37 pregnancies (8%) were found in the PP genotype Results (Table IV) . This distribution of genotypes was statistically different from that in both the IVF patients and the control Frequencies of PvuII positive (P) and negative (p) ESR alleles, present in the IVF group, did not differ significantly with the group (Table I ; P Ͻ 0.05).
A comparison between PvuII genotype groups with tubal control group. The frequency of BstUI positive (B) alleles was low in the IVF and control groups, and so was the Bb genotype or unexplained infertility was not statistically significant and neither was the number of HMG ampoules and the duration (Table I) .
Only one BB genotype was found in the IVF group while of HMG administration. The ESR B variant, which was analysed using the restriction none was found in the control group (Table I) . The observed haplotypes were p-b, P-b, p-B and P-B, with equal frequencies enzyme BstUI, was not found to have an influence on the numbers of the follicles, oocytes and ratios, when compared study, the rare P-B haplotype was present only in the IVF group but not in the controls and the pregnancies resulting alone or in combination with PvuII. Nevertheless, this variant was rare in homozygosity and in the same haplotype with a from IVF and embryo transfer. The fact that ESR B was found in two IVF patients to be associated with PvuII positive PvuII positive restriction site. genotype in our study reflects the evolutionary disadvantage for fertility of the P-B haplotype.
Discussion
The incidence of P-B haplotype in our population could not be compared to other populations since haplotype data are Various factors have been associated with the outcome of IVF treatment since the advent of assisted reproduction (Edwards lacking in the literature. Nevertheless, this very low incidence is partly explained by the rare genotype BB which is also et al., 1984) . Those affecting follicular growth, steroidogenesis and maturation of oocytes were among the first recognized as present only in the IVF group. This is also demonstrated by the rarity of the BB genotype in a New York City-based crucial (Fowler et al., 1978; Testart et al., 1983) . Studies implementing oestradiol measurements have already demonpopulation and its presence in spontaneous abortions (Lehrer et al., 1993) . strated a direct effect of oestrogens on the maturation of follicular oocytes (Fowler et al., 1977) . High oestradiol values
In conclusion, our preliminary data present some evidence that genetic variability of the ESR gene may result in variability in the follicular fluid were associated with the recovery of fertilizable oocytes (Fishel et al., 1983) , although this has been in the content of the ovarian follicles, as it is found after stimulation and may also affect implantation. Certain rare ESR disputed (Messinis and Templeton, 1987) .
In this study we have analysed polymorphisms in the ESR genotypes and haplotypes seem to confer a disadvantage to fertility in terms of an ineffective mediation of oestrogens in gene in an attempt to elucidate the role of the ESR in ovulation induction and implantation. Genetic variability, to human endometrium and throughout follicular development. our knowledge, has not yet been suggested as a risk factor in infertility, with the exception of the infertility associated
